Literature DB >> 32398808

Oxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine.

Chunju Fang1,2, Fei Mo1, Li Liu1, Jing Du1, Min Luo1, Ke Men1, Feifei Na1, Wei Wang1, Hanshuo Yang1, Xiawei Wei3.   

Abstract

Exposure to ionizing radiation, a physical treatment that inactivates live tumor cells, has been extensively applied to enhance the antitumor responses induced by cancer cell vaccines in both animal research and human clinical trials. However, the mechanisms by which irradiated cells function as immunogenic tumor vaccines and induce effective antitumor responses have not been fully explored. Here, we demonstrate that oxidized mitochondrial DNA (mtDNA) and stimulator of interferon genes (STING) signaling play a key roles in the enhanced antitumor effect achieved with an irradiated tumor cell vaccine. Elevations in ROS and oxidized mtDNA 8-OHG content could be induced in irradiated tumor cells. Oxidized mtDNA derived from irradiated tumor cells gained access to the cytosol of dendritic cells (DCs). Oxidized mtDNA, as a DAMP or adjuvant, activated the STING-TBK1-IRF3-IFN-β pathway in DCs, which subsequently cross-presented irradiated tumor cell-derived antigens to CD8+ T cells and elicited antitumor immunity. The results of our study provide insight into the mechanism by which an irradiated cell vaccine mediates antitumor immunity, which may have implications for new strategies to improve the efficacy of irradiated vaccines.
© 2020. The Author(s).

Entities:  

Keywords:  Irradiated tumor cell vaccine; Oxidized mitochondrial DNA; STING signaling

Mesh:

Substances:

Year:  2020        PMID: 32398808      PMCID: PMC8429462          DOI: 10.1038/s41423-020-0456-1

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   22.096


  49 in total

1.  gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

Authors:  Douglas J Schwartzentruber; David H Lawson; Jon M Richards; Robert M Conry; Donald M Miller; Jonathan Treisman; Fawaz Gailani; Lee Riley; Kevin Conlon; Barbara Pockaj; Kari L Kendra; Richard L White; Rene Gonzalez; Timothy M Kuzel; Brendan Curti; Phillip D Leming; Eric D Whitman; Jai Balkissoon; Douglas S Reintgen; Howard Kaufman; Francesco M Marincola; Maria J Merino; Steven A Rosenberg; Peter Choyke; Don Vena; Patrick Hwu
Journal:  N Engl J Med       Date:  2011-06-02       Impact factor: 91.245

Review 2.  Whole cell vaccines--past progress and future strategies.

Authors:  Bridget P Keenan; Elizabeth M Jaffee
Journal:  Semin Oncol       Date:  2012-06       Impact factor: 4.929

3.  Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis.

Authors:  M Obeid; T Panaretakis; N Joza; R Tufi; A Tesniere; P van Endert; L Zitvogel; G Kroemer
Journal:  Cell Death Differ       Date:  2007-07-27       Impact factor: 15.828

4.  Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Authors:  Philip W Kantoff; Celestia S Higano; Neal D Shore; E Roy Berger; Eric J Small; David F Penson; Charles H Redfern; Anna C Ferrari; Robert Dreicer; Robert B Sims; Yi Xu; Mark W Frohlich; Paul F Schellhammer
Journal:  N Engl J Med       Date:  2010-07-29       Impact factor: 91.245

5.  Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for glioma.

Authors:  Martin K Hunn; Kathryn J Farrand; Kate W R Broadley; Robert Weinkove; Peter Ferguson; Rose J Miller; Cameron S Field; Troels Petersen; Melanie J McConnell; Ian F Hermans
Journal:  Clin Cancer Res       Date:  2012-11-12       Impact factor: 12.531

Review 6.  Strategies to improve radiotherapy with targeted drugs.

Authors:  Adrian C Begg; Fiona A Stewart; Conchita Vens
Journal:  Nat Rev Cancer       Date:  2011-04       Impact factor: 60.716

7.  Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.

Authors:  Lorenzo Mortara; Valeria Frangione; Patrizia Castellani; Andrea De Lerma Barbaro; Roberto S Accolla
Journal:  Int Immunol       Date:  2009-04-24       Impact factor: 4.823

8.  Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial.

Authors:  J B Vermorken; A M Claessen; H van Tinteren; H E Gall; R Ezinga; S Meijer; R J Scheper; C J Meijer; E Bloemena; J H Ransom; M G Hanna; H M Pinedo
Journal:  Lancet       Date:  1999-01-30       Impact factor: 79.321

9.  Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

Authors:  James A Bonner; Paul M Harari; Jordi Giralt; Nozar Azarnia; Dong M Shin; Roger B Cohen; Christopher U Jones; Ranjan Sur; David Raben; Jacek Jassem; Roger Ove; Merrill S Kies; Jose Baselga; Hagop Youssoufian; Nadia Amellal; Eric K Rowinsky; K Kian Ang
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

10.  Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.

Authors:  Jaikumar Duraiswamy; Karen M Kaluza; Gordon J Freeman; George Coukos
Journal:  Cancer Res       Date:  2013-04-30       Impact factor: 12.701

View more
  12 in total

Review 1.  Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts.

Authors:  Dietrich Averbeck; Claire Rodriguez-Lafrasse
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

Review 2.  The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.

Authors:  Sara Hadjigol; Bansari A Shah; Neil M O'Brien-Simpson
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

Review 3.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

Review 4.  STING, the Endoplasmic Reticulum, and Mitochondria: Is Three a Crowd or a Conversation?

Authors:  Judith A Smith
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

Review 5.  The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.

Authors:  Quinn Storozynsky; Mary M Hitt
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

6.  A novel inactivated whole-cell Pseudomonas aeruginosa vaccine that acts through the cGAS-STING pathway.

Authors:  Cuicui Ma; Xiao Ma; Boguang Jiang; Hailong Pan; Xueyuan Liao; Li Zhang; Wenfang Li; Yingjie Luo; Zhixue Shen; Xingjun Cheng; Mao Lian; Zhenling Wang
Journal:  Signal Transduct Target Ther       Date:  2021-10-01

7.  STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer.

Authors:  Yanyan Da; Yuxia Liu; Yuan Hu; Wenzeng Liu; Junpeng Ma; Nan Lu; Chengsheng Zhang; Cai Zhang
Journal:  Oncoimmunology       Date:  2022-03-21       Impact factor: 8.110

8.  Abscopal Effects of Local Radiotherapy Are Dependent on Tumor Immunogenicity.

Authors:  Jin-Zhi Lai; Yan-Yang Zhu; Ying Liu; Lin-Lin Zhou; Li Hu; Ling Chen; Qiu-Yu Zhang
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

Review 9.  The cGAS-STING Pathway: A Promising Immunotherapy Target.

Authors:  Liang Ou; Ao Zhang; Yuxing Cheng; Ying Chen
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

Review 10.  Mitochondrial DNA on Tumor-Associated Macrophages Polarization and Immunity.

Authors:  Yaxin Guo; Hsiang-I Tsai; Lirong Zhang; Haitao Zhu
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.